Cargando…
Validation Study on Risk-Reduction Activities after Exposure to a Personalized Breast Cancer Risk-Assessment Education Tool in High-Risk Women in the WISDOM Study
We performed a 318-participant validation study of an individualized risk assessment tool in women identified as having high- or highest-risk of breast cancer in the personalized arm of the Women Informed to Screen Depending on Measures of risk (WISDOM) trial. Per protocol, these women were educated...
Autores principales: | Wang, Tianyi, Che, Mandy, Huilgol, Yash S, Keane, Holly, Goodman, Deborah, Soonavala, Rashna, Ozanne, Elissa, Shieh, Yiwey, Belkora, Jeffrey K, Fiscalini, Allison Stover, Esserman, Laura J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197747/ https://www.ncbi.nlm.nih.gov/pubmed/37214889 http://dx.doi.org/10.21203/rs.3.rs-2787493/v1 |
Ejemplares similares
-
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial
por: Keane, Holly, et al.
Publicado: (2021) -
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry
por: Huilgol, Yash S., et al.
Publicado: (2021) -
The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
por: Eklund, Martin, et al.
Publicado: (2019) -
Development of a personalized decision aid for breast cancer risk reduction and management
por: Ozanne, Elissa M, et al.
Publicado: (2014) -
The WISDOM Study: breaking the deadlock in the breast cancer screening debate
por: Esserman, Laura J.
Publicado: (2017)